跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 102 条关于
“carcinosarcoma”
全部
102
临床试验
88
药物
0
机构
0
资讯
14
去年
FDA Expands Dostarlimab Approval for Advanced Endometrial Cancer Based on RUBY Trial
2年前
PharmaMar's Trabectedin Expands Development Portfolio with Multiple Cancer Indications
去年
FR-alpha and B7-H4 Expression Found in Over 80% of Endometrial Cancer Cases, Supporting ADC Development
2年前
Pembrolizumab Fails to Improve DFS in High-Risk Endometrial Cancer, Shows Benefit in dMMR Subgroup
2年前
Pembrolizumab Fails to Improve DFS in High-Risk Endometrial Cancer, Shows Promise in dMMR Subgroup
2年前
Pembrolizumab Plus Chemotherapy Demonstrates DFS Benefit in dMMR Endometrial Cancer Subgroup
3个月前
Frontiers Launches Research Topic on Personalized Approaches in Gynecologic Oncology, Highlighting Precision Medicine and Rare Tumor Challenges
去年
HER2-Directed ADCs Expand Treatment Spectrum Across Solid Tumors
去年
Puxitatug Samrotecan Shows Promise in Advanced Endometrial Cancer with 38% Response Rate
2年前
Dostarlimab Shows Superior Survival Outcomes Across Multiple Endometrial Cancer Molecular Subgroups in Phase 3 RUBY Trial
第 1 页,共 2 页
上一页
下一页